Posted in

Mission Fertility 2.1: Key Reforms for IVF Cover in India

Radiologist analysing CT and MRI scans on a digital workstation, showcasing key imaging modalities used in diagnostic radiology.

A landmark white paper released on World IVF Day recommends urgent structural policy changes to expand IVF access in India. The report proposes introducing fertility benefits under Ayushman Bharat-PMJAY, mandating workplace wellness cover, and reforming private health insurance schemes. Consequently, these measures aim to address the growing burden of infertility across the nation.

Addressing the Massive Gap in IVF Access in India

Currently, an estimated 3.5 crore couples in India struggle with infertility. However, only 42 lakh individuals successfully receive assisted reproductive treatments. This stark disparity underscores severe financial barriers and widespread social stigma. Furthermore, India’s total fertility rate has dropped below the replacement level of 2.1, highlighting the urgent need for systemic reproductive healthcare reform.

Key Policy Recommendations for Insurance and Public Coverage

The white paper, titled Beyond the Burden of Infertility in India: Towards Reproductive Equity through Mission Fertility 2.1, outlines essential policy interventions. First, it urges private insurers to reduce waiting periods and expand cover for assisted reproductive technologies. Second, the report calls for modernising reimbursement mechanisms under CGHS, ESIC, and public sector undertakings. Additionally, integrating employer-sponsored fertility benefits can significantly ease the financial strain on working couples.

Strengthening Awareness and Public Healthcare Integration

Promoting early diagnosis and public education remains vital for improving clinical outcomes. Therefore, experts advocate utilizing community health workers like ASHAs to spread awareness about male and female fertility. In addition, strengthening public-private partnerships will make advanced reproductive science accessible to lower-income families. Thus, transforming infertility care into an essential healthcare component ensures every couple gets an equitable opportunity to build a family.

Frequently Asked Questions

Q1: Why is IVF access in India considered a critical public health priority?

Infertility affects millions of couples in India, yet high out-of-pocket costs and limited insurance coverage prevent the vast majority from accessing treatment. Therefore, integrating fertility care into public health programs is essential for reproductive equity.

Q2: Does Ayushman Bharat PM-JAY currently cover IVF treatments?

Currently, routine IVF is not covered under Ayushman Bharat PM-JAY. However, experts and recent policy white papers strongly advocate introducing a dedicated fertility benefit package for economically vulnerable families.

Q3: What reforms are recommended for private health insurance regarding fertility care?

Experts recommend reducing long waiting periods, capping out-of-pocket expenses, removing exclusions on assisted reproductive technology, and offering fertility add-on coverage in standard health policies.

You can also explore various women’s health speciality courses to further enhance your expertise in this field.

References

  1. White paper seeks insurance reforms, Ayushman Bharat fertility cover to improveIVF access – ETHealthworld
  2. Integrated Health & Wellbeing Council. Beyond the Burden of Infertility in India: Towards Reproductive Equity through Mission Fertility 2.1 White Paper. Published July 2026.
  3. National Family Health Survey (NFHS-5) & Indian Council of Medical Research (ICMR) Reproductive Health Guidelines.

Disclaimer: This article was automatically generated from publicly available sources and is provided for informational and educational purposes only. OC Academy does not exercise editorial control or claim authorship over this content. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider and refer to current local and national clinical guidelines.

Leave a Reply

Your email address will not be published. Required fields are marked *